On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021
- PMID: 34648959
- DOI: 10.1016/j.neuroimage.2021.118646
On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021
Comment in
-
Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021".Neuroimage. 2022 May 1;251:118992. doi: 10.1016/j.neuroimage.2022.118992. Epub 2022 Feb 15. Neuroimage. 2022. PMID: 35181550 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
